Article: Nicotinamide Riboside Prevents Low Kidney Nephron Numbers Caused by Maternal Protein Restriction: Preclinical Findings

PrevNext
Kidney Disease Kidney Health Preclinical Reproductive Health

Nicotinamide Riboside Prevents Low Kidney Nephron Numbers Caused by Maternal Protein Restriction: Preclinical Findings

Synopsis

Babies born with fewer nephrons (kidney filters), often due to poor maternal nutrition, have higher risk for kidney disease and high blood pressure later. There are no current treatments to increase nephron numbers. This study showed that in mice born to mothers on a low-protein diet, kidney SIRT3 (a protective enzyme) levels were low, and nephron number was reduced. Giving nicotinamide riboside (NR), a NAD+ precursor that activates SIRT3, restored SIRT3 levels and activity, improved kidney structure, and protected mitochondria from damage. These findings suggest that boosting SIRT3 with NR during kidney development could prevent nephron loss and its long-term health effects.

Journal

Cells

Share

Read more

Kidney Disease

Nicotinamide Riboside Protects Against Chronic Kidney Disease by Boosting Metabolism: Preclinical Findings

SynopsisChronic kidney disease (CKD) impairs kidney metabolism, including fatty acid breakdown, and is linked to low NAD+ levels. This study tested nicotinamide riboside (NR), a precursor of NAD+, ...

Read more
Liver Health

Nicotinamide Riboside Prevents Liver Injury and Restores Mitochondrial Function: Preclinical Findings

SynopsisNAMPT is an enzyme that helps make NAD+. Since low liver NAD+ is linked to fatty liver disease, scientists removed NAMPT specifically from liver cells in mice to see the effect. These mice ...

Read more